Congressman Scott Garrett

Representing the 5th District of New Jersey

Health Care

stethoscope on a clipboard

 

More on Health Care

Sep 21, 2016

WASHINGTON, D.C. – Rep. Scott Garrett (NJ-05) issued the following statement after the Food and Drug Administration (FDA) this week announced the accelerated approval for a new treatment for Duchenne muscular dystrophy:

Sep 21, 2016

WASHINGTON, D.C. – Rep. Scott Garrett (NJ-05) called on the Food and Drug Administration (FDA) to express concerns over the near monopoly currently held by Mylan Pharmaceuticals on the EpiPen (epinephrine injection) which is used in the treatment of severe allergic reactions. The price of these life-saving devices has skyrocketed recently, making them unaffordable for many Americans families.

Feb 2, 2016

WASHINGTON, D.C. – Rep. Scott Garrett (NJ-05) issued the following statement after voting for H.R. 3762, the Restoring Americans’ Healthcare Freedom Reconciliation Act, Objections of the President Notwithstanding:

Jan 12, 2016

WASHINGTON, D.C. – Rep. Scott Garrett (NJ-05) issued the following statement after President Obama delivered his final State of the Union address:

Jan 6, 2016

WASHINGTON, D.C. – Rep. Scott Garrett (NJ-05), a senior member of the House Budget Committee, issued the following statement after the House voted for the Restoring Americans' Healthcare Freedom Reconciliation Act, a budget reconciliation bill which would repeal ObamaCare:

Oct 23, 2015

WASHINGTON, D.C. – Rep. Scott Garrett (NJ-05), a senior member of the House Budget Committee, issued the following statement after supporting H.R. 3762, the Restoring Americans’ Healthcare Freedom Reconciliation Act:

Jun 25, 2015

WASHINGTON, D.C. – Rep. Scott Garrett (NJ-05), Chairman of the Congressional Constitution Caucus, issued the following statement in response to the Supreme Court’s ruling on King v. Burwell:

Mar 4, 2014

The Record

By Rep. Scott Garrett

Despite not knowing your situation or your specific needs, perfect strangers now decide what is best for you.

Feb 9, 2014

New Jersey Herald

By Rep. Scott Garrett

Feb 4, 2014

Washington, DC – Rep. Scott Garrett (R-NJ), senior member of the House Budget Committee and Chairman of the Financial Services Subcommittee on Capital Markets and Government-Sponsored Enterprises, issued the following statement regarding the Congressional Budget Office’s (CBO) Budget and Economic Outlook for 2014-2024: